We recorded the percentage and intensity of antigen expression of CLL makers, including CD5, CD20, CD23, CD79b, CD200 and sIgM, and assessed whether these affected the adapted and modified Matutes scores. The gene discussed is CD5; the disease is B-cell chronic lymphocytic leukemia.